ARCHIVES

FDA Committee Oks AMSA for Group C List, Tables THC Request, Deadlocks On Estramustine NDA

This article is from The Cancer Letter archive.

Vol. 07 No. 27 | July 3, 1981

Download PDF Visit The Full Archive

Related Articles

ODAC Advises Approval Of Tamoxifen For Male Breast Cancer Treatment

November 27, 1992

No Difference in Toxicity Between IMRT and PRT In Medicare Patients

January 25, 2013

NCI Get Go-Ahead For New Cancer Control Projects Totaling $7.4 Million, Funded By Grants, Contracts

October 21, 1977

Black-White Disparity Seen In End Of Life Treatment

November 27, 2009

Rauscher Disappointed In CREG Progress

October 1, 1976

In Brief: Cancer Center Founder In Bosnia Seeks Attention From Colleagues: Phone Calls Will Help, He Says

January 22, 1993